Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies

von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020 · see citing works

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61602-x · Cited by 21,320 · see citing works

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203 · see citing works

Untitled work

(2013) · doi:10.1097/01.aog.0000437382.03963.88 · Cited by 3,961 · see citing works

The Antiphospholipid Syndrome

Levine, J. S., Branch, D. W., & Rauch, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra002974 · Cited by 1,524 · see citing works

Update of the guidelines for lupus anticoagulant detection

PENGO, V., TRIPODI, A., REBER, G., RAND, J. H., ORTEL, T. L., GALLI, M., & DE GROOT, P. G. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03555.x · Cited by 1,197 · see citing works

Thrombophilia in pregnancy: a systematic review

Robertson, L., Wu, O., Langhorne, P., Twaddle, S., Clark, P., Lowe, G. D. O., Walker, I. D., Greaves, M., Brenkel, I., Regan, L., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05847.x · Cited by 849 · see citing works

2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial

Lees, C. C., Marlow, N., van Wassenaer-Leemhuis, A., Arabin, B., Bilardo, C. M., Brezinka, C., Calvert, S., Derks, J. B., Diemert, A., Duvekot, J. J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62049-3 · Cited by 479 · see citing works

The Second International Anti-Cardiolipin Standardization Workshop/The Kingston Anti-Phospholipid Antibody Study (KAPS) Group

Harris, E. N. (1990) · American Journal of Clinical Pathology · doi:10.1093/ajcp/94.4.476 · Cited by 416 · see citing works

A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy

Branch, D. W., Peaceman, A. M., Druzin, M. L., Silver, R. K., El-Sayed, Y. Y., Silver, R. M., Esplin, M. S., Spinnato, J. A., & Harger, J. H. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70500-x · Cited by 315 · see citing works

Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials

Empson, M. B. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01646-5 · Cited by 293 · see citing works

Regression modelling and other methods to control confounding

McNamee, R. (2005) · Occupational and Environmental Medicine · doi:10.1136/oem.2002.001115 · Cited by 251 · see citing works

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases

Alijotas‐Reig, J., Esteve‐Valverde, E., Ferrer‐Oliveras, R., Comet, L. S., Lefkou, E. E., MEKINIAN, A., Belizna, C. C., Ruffatti, A., Tincani, A., Marozio, L., et al. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.12.006 · Cited by 215 · see citing works

Practice Bulletin No. 132

(2012) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000423816.39542.0f · Cited by 209 · see citing works

New Inventions

Dewhurst, C. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90397-6 · Cited by 187 · see citing works

LUPUS ANTICOAGULANT AND RECURRENT FETAL LOSS: SUCCESSFUL TREATMENT WITH GAMMAGLOBULIN

Carreras, L., Pérez, G., Vega, H. R., & CASAVILLA, F. A. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92859-0 · Cited by 173 · see citing works

Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study

Kim, M., Buyon, J. P., Guerra, M. M., Rana, S., Zhang, D., Laskin, C. A., Petri, M., Lockshin, M. D., Sammaritano, L. R., Branch, D. W., et al. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.09.066 · Cited by 173 · see citing works

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases

Alijotas‐Reig, J., Ferrer‐Oliveras, R., Ruffatti, A., Tincani, A., Lefkou, E. E., Bertero, M. T., Coloma, E., Carolis, S. D., Espinosa, G., Rovere, P. Q., et al. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.12.010 · Cited by 152 · see citing works

Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization

Scott, J. R., Branch, D. W., Kochenour, N. K., & Ward, K. J. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90411-5 · Cited by 136 · see citing works

Confidence Limit Analyses Should Replace Power Calculations in the Interpretation of Epidemiologic Studies

Smith, A. H., & Bates, M. N. (1992) · Epidemiology · doi:10.1097/00001648-199209000-00011 · Cited by 128 · see citing works

Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy

Spinnato, J. A., Clark, A. L., Pierangeli, S. S., & Harris, E. N. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90595-2 · Cited by 114 · see citing works

Association of Anticardiolipin Antibodies With Preeclampsia

do Prado, A. D., Piovesan, D. M., Staub, H. L., & Horta, B. L. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181fe02ec · Cited by 110 · see citing works

Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials

Rote, N. S. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02061-6 · Cited by 77 · see citing works

Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management—An Insight into Future Approaches

Chighizola, C. B., Ubiali, T., & Meroni, P. L. (2015) · Journal of Immunology Research · doi:10.1155/2015/951424 · Cited by 67 · see citing works

Coumarin derivatives and breast-feeding

Clark, S. L. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)00809-7 · Cited by 66 · see citing works

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada

Blackhouse, G., Gaebel, K., Xie, F., Campbell, K., Assasi, N., Tarride, J., O’Reilly, D. J., Chalk, C., Levine, M., & Goeree, R. A. (2010) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-8-14 · Cited by 58 · see citing works

Brief report: changes in antiphospholipid antibody titers during pregnancy: effects on pregnancy outcomes

Yelnik, C. M., Porter, T. F., Branch, D. W., Laskin, C. A., Merrill, J. T., Guerra, M. M., Lockshin, M. D., Buyon, J. P., Petri, M., Sammaritano, L. R., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39668 · Cited by 54 · see citing works

Recurrent first trimester spontaneous abortion associated with antiphospholipid antibodies:

Marzusch, K., Dietl, J., Klein, R., Hornung, D., Neuer, A., & Berg, P. A. (1996) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349609055029 · Cited by 52 · see citing works

Utilization of intravenous immunoglobulin therapy to treat recurrent pregnancy loss in the antiphospholipid syndrome: a review

Harris, E. N., & Pierangeli, S. S. (1998) · Scandinavian Journal of Rheumatology · doi:10.1080/03009742.1998.11720777 · Cited by 26 · see citing works

Anti‐β2 glycoprotein I antibodies and pregnancy outcome in antiphospholipid syndrome

Liu, X. L., Xiao, J., & Zhu, F. (2012) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12038 · Cited by 10 · see citing works

Untitled work

Wilson (1999) · doi:10.1002/1529-0131(199907)42:7

EULAR recommendations for the management of antiphospholipid syndrome in adults

Tektonidou, M. G., Andreoli, L., Limper, M., Amoura, Z., Cervera, R., Costedoat-Chalumeau, N., Cuadrado, M. J., Dörner, T., Ferrer-Oliveras, R., Hambly, K., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215213 · Cited by 1,261 · see citing works

Interferons and Proinflammatory Cytokines in Pregnancy and Fetal Development

Yockey, L. J., & Iwasaki, A. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.017 · Cited by 567 · see citing works

The etiology of preeclampsia

Jung, E., Romero, R. J., Yeo, L., Gomez‐Lopez, N., Chaemsaithong, P., Jaovisidha, A., Gotsch, F., & Erez, O. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.11.1356 · Cited by 605 · see citing works

Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management

Knight, J. S., Branch, D. W., & Ortel, T. L. (2023) · BMJ · doi:10.1136/bmj-2021-069717 · Cited by 284 · see citing works

Exercise during pregnancy and risk of gestational hypertensive disorders: a systematic review and meta‐analysis

Malosso, E. R. M., Saccone, G., Tommaso, M. D., Roman, A., & Berghella, V. (2017) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13151 · Cited by 259 · see citing works

Indications for Outpatient Antenatal Fetal Surveillance

(2021) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004407 · Cited by 151 · see citing works

Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review

Alijotas‐Reig, J., Esteve‐Valverde, E., Anunciación-Llunell, A., Marques-Soares, J. R., Pardos‐Gea, J., & Miró‐Mur, F. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030675 · Cited by 127 · see citing works

Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome

Cornish, E. F., McDonnell, T. C. R., & Williams, D. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.825075 · Cited by 118 · see citing works

First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume

Sonek, J., Krantz, D., Carmichael, J., Downing, C., Jessup, K., Haidar, Z. A., Ho, S., Hallahan, T., Kliman, H. J., & McKenna, D. S. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.10.024 · Cited by 113 · see citing works

Emerging Treatment Models in Rheumatology: Antiphospholipid Syndrome and Pregnancy: Pathogenesis to Translation

Abrahams, V. M., Chamley, L., & Salmon, J. E. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40136 · Cited by 104 · see citing works

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults

Tektonidou, M. G., Andréoli, L., Limper, M., Tincani, A., & Ward, M. M. (2019) · RMD Open · doi:10.1136/rmdopen-2019-000924 · Cited by 99 · see citing works

Pregnancy outcome predictors in antiphospholipid syndrome: A systematic review and meta-analysis

Walter, I. J., Haneveld, M. J. K., Lely, A. T., Bloemenkamp, K. W. M., Limper, M., & Kooiman, J. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102901 · Cited by 93 · see citing works

The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus

Giacomelli, R., Afeltra, A., Bartoloni, E., Berardicurti, O., Bombardieri, M., Bortoluzzi, A., Carubbi, F., Caso, F., Cervera, R., Ciccia, F., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102738 · Cited by 78 · see citing works

Antiphospholipid syndrome: An update on risk factors for pregnancy outcome

Carolis, S. D., Tabacco, S., Rizzo, F., Giannini, A., Botta, A., Salvi, S., Garufi, C., Panici, P. B., & Lanzone, A. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.03.018 · Cited by 76 · see citing works

EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies

Pregnolato, F., Gerosa, M., Raimondo, M. G., Comerio, C., Bartoli, F., Lonati, P. A., Borghi, M. O., Acaia, B., Ossola, M. W., Ferrazzi, E. M., et al. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa203 · Cited by 76 · see citing works

The pathogenic role of autoantibodies in recurrent pregnancy loss

D’Ippolito, S., Ticconi, C., Tersigni, C., Garofalo, S., Martino, C., Lanzone, A., Scambia, G., & Simone, N. D. (2019) · American Journal of Reproductive Immunology · doi:10.1111/aji.13200 · Cited by 72 · see citing works

Thrombocytopenia in pregnancy: Diagnosis and approach to management

Pishko, A. M., Levine, L. D., & Cines, D. B. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100638 · Cited by 70 · see citing works

The potential therapeutic effects of ergothioneine in pre-eclampsia

Kerley, R. N., McCarthy, C., Kell, D. B., & Kenny, L. C. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.030 · Cited by 68 · see citing works

Does low-dose aspirin initiated before 11 weeks’ gestation reduce the rate of preeclampsia?

Chaemsaithong, P., Cuenca-Gómez, D., Plana, N., Gil, M. M., & Poon, L. C. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.08.047 · Cited by 70 · see citing works

Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father†

Kenny, L. C., & Kell, D. B. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2017.00239 · Cited by 69 · see citing works

Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms

D’Ippolito, S., Barbaro, G., Paciullo, C., Tersigni, C., Scambia, G., & Simone, N. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043195 · Cited by 69 · see citing works

Antiphospholipid syndrome management: a 2023 update and practical algorithm-based approach

Ambati, A., Knight, J. S., & Zuo, Y. (2023) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000932 · Cited by 65 · see citing works

Prophylactic use of tranexamic acid after vaginal delivery reduces the risk of primary postpartum hemorrhage

Saccone, G., Corte, L. D., D’Alessandro, P., Ardino, B., Carbone, L., Raffone, A., Guida, M., Locci, M., Zullo, F., & Berghella, V. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1571576 · Cited by 60 · see citing works

Lupus Anticoagulant Identifies Two Distinct Groups of Patients with Different Antibody Patterns

Pengo, V., Del Ross, T., Ruffatti, A., Bison, E., Cattini, M. G., Pontara, E., Testa, S., Legnani, C., Pozzi, N., Peterle, D., et al. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.11.003 · Cited by 59 · see citing works

Tranexamic acid for treatment of primary postpartum hemorrhage after vaginal delivery: a systematic review and meta-analysis of randomized controlled trials

Corte, L. D., Saccone, G., Locci, M., Carbone, L., Raffone, A., Giampaolino, P., Ciardulli, A., Berghella, V., & Zullo, F. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1500544 · Cited by 53 · see citing works

Pregnancy outcomes in patients with primary antiphospholipid syndrome

Liu, L., & Sun, D. (2019) · Medicine · doi:10.1097/md.0000000000015733 · Cited by 53 · see citing works

Placental morphology, apoptosis, angiogenesis and epithelial mechanisms in early-onset preeclampsia

Travaglino, A., Raffone, A., Saccone, G., Migliorini, S., Maruotti, G. M., Esposito, G., Mollo, A., Martinelli, P., Zullo, F., & D'Armiento, M. R. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.12.039 · Cited by 51 · see citing works

Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies

Fredi, M., Andréoli, L., Aggogeri, E., Bettiga, E., Lazzaroni, M. G., Guern, V. L., Lojacono, A., Morel, N., Piette, J. C., Zatti, S., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00864 · Cited by 50 · see citing works

The prediction of fetal death with a simple maternal blood test at 24-28 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio)

Chaiworapongsa, T., Romero, R. J., Erez, O., Tarca, A. L., Conde‐Agudelo, A., Chaemsaithong, P., Kim, C. J., Kim, Y. M., Kim, J.-S., Yoon, B. H., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.10.001 · Cited by 47 · see citing works

Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies

Lazzaroni, M. G., Fredi, M., Andréoli, L., Chighizola, C. B., Ross, T. D., Gerosa, M., Kuzenko, A., Raimondo, M.-G., Lojacono, A., Ramazzotto, F., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01948 · Cited by 50 · see citing works

Stillbirth: prevention and supportive bereavement care

Atkins, B., Kindinger, L. M., Mahindra, M. P., Moatti, Z., & Siassakos, D. M. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2022-000262 · Cited by 48 · see citing works

The Extended Use of Eculizumab in Pregnancy and Complement Activation–Associated Diseases Affecting Maternal, Fetal and Neonatal Kidneys—The Future Is Now?

Stefanović, V. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030407 · Cited by 45 · see citing works

Antiphospholipid Antibody Syndrome and Infertility

Rodrigues, V. D. O., Soligo, A. D. G. E. S., & Pannain, G. D. (2019) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0039-1697982 · Cited by 48 · see citing works

The association between antiphospholipid antibodies and late fetal loss: A systematic review and meta‐analysis

Xu, J., Chen, D., Duan, X., Li, L., Tang, Y., & Peng, B. (2019) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13665 · Cited by 43 · see citing works

Determinants of placental insufficiency in fetal growth restriction

Dall’Asta, A., Melito, C., Morganelli, G., Lees, C. C., & Ghi, T. (2022) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.26111 · Cited by 40 · see citing works

Evaluation of Recurrent Pregnancy Loss

de Assis, V., Schenone, C. V., & Ros, S. T. (2024) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005498 · Cited by 45 · see citing works

Antenatal intervention for congenital fetal lower urinary tract obstruction (LUTO): a systematic review and meta-analysis

Saccone, G., D’Alessandro, P., Escolino, M., Esposito, R., Arduino, B., Vitagliano, A., Quist‐Nelson, J., Berghella, V., Esposito, C., & Zullo, F. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1555704 · Cited by 39 · see citing works

Serum markers of B‐cell activation in pregnancy during late gestation, delivery, and the postpartum period

de Lima, J. J. A. V., Cambridge, G., Vilas‐Boas, A., Martins, C. G., Borrego, L. M., & Leandro, M. J. (2019) · American Journal of Reproductive Immunology · doi:10.1111/aji.13090 · Cited by 37 · see citing works

16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome

de Jesús, G. R., Benson, A. E., Chighizola, C. B., Sciascia, S., & Branch, D. W. (2020) · Lupus · doi:10.1177/0961203320954520 · Cited by 35 · see citing works

Preeclampsia and the Antiphospholipid Syndrome

Mayer-Pickel, K. I., Nanda, M., Gajić, M., & Cervar-Zivkovic, M. (2023) · Biomedicines · doi:10.3390/biomedicines11082298 · Cited by 33 · see citing works

Therapeutic apheresis during pregnancy: A single center experience

Colpo, A., Marson, P., Pavanello, F., Tison, T., Gervasi, M. T., Zambon, A., Ruffatti, A., Silvestro, G. D., & Hoxha, A. (2019) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2019.07.009 · Cited by 32 · see citing works

Adverse pregnancy outcomes in women with systemic lupus erythematosus: can we improve predictions with machine learning?

Fazzari, M. J., Guerra, M. M., Salmon, J. E., & Kim, M. (2022) · Lupus Science & Medicine · doi:10.1136/lupus-2022-000769 · Cited by 30 · see citing works

Pre-Eclampsia: From Etiology and Molecular Mechanisms to Clinical Tools—A Review of the Literature

Tabacco, S., Ambrosii, S., Polsinelli, V., Fantasia, I., D’Alfonso, A., Ludovisi, M., Cecconi, S., & Guido, M. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080391 · Cited by 34 · see citing works

Impact of extractable nuclear antigen, anti-double stranded DNA, antiphospholipid antibody, and anticardiolipin antibody positivity on obstetrical complications and pregnancy outcomes

Tanaçan, A., Beksaç, M. S., Örgül, G., Duru, S. A., Şener, B., & Karaağaoğlu, E. (2019) · Human Antibodies · doi:10.3233/hab-180359 · Cited by 30 · see citing works

Antiphospholipid syndrome: Diagnosis and management in the obstetric patient

Arslan, E., & Branch, D. W. (2019) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2019.10.001 · Cited by 30 · see citing works

How I diagnose and treat antiphospholipid syndrome in pregnancy

Branch, D. W., & Lim, M. Y. (2023) · Blood · doi:10.1182/blood.2023020727 · Cited by 29 · see citing works

Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndrome

Agmon‐Levin, N., Volkov, I., Seguro, L., Leon, E. P., Kovács, L., Roggenbuck, D., Schierack, P., Gilburd, B., Doria, A., Tektonidou, M. G., et al. (2020) · Autoimmunity Highlights · doi:10.1186/s13317-020-00131-3 · Cited by 29 · see citing works

High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant

Gebhart, J., Posch, F., Koder, S., Quehenberger, P., Perkmann, T., Kuessel, L., Ay, C., & Pabinger, I. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018026948 · Cited by 29 · see citing works

Risk Factors for Preeclampsia

Shiozaki, A., & Saito, S. (2018) · Comprehensive Gynecology and Obstetrics · doi:10.1007/978-981-10-5891-2_1 · Cited by 28 · see citing works

Dilemmas in the diagnosis and management of antiphospholipid syndrome

Manning, J. E., & Arachchillage, D. J. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.03.027 · Cited by 30 · see citing works

Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial

Branch, D. W., Kim, M., Guerra, M. M., Worden, J., Laskin, C. A., DeSancho, M. T., Landres, I. V., Knight, J. S., Slosberg, H. S., Minett, M., et al. (2025) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2025.02.012 · Cited by 29 · see citing works

Update on Antiphospholipid Syndrome: Ten Topics in 2017

Cavazzana, I., Andréoli, L., Limper, M. A., Franceschini, F., & Tincani, A. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0718-4 · Cited by 28 · see citing works

Clinical characteristics and prognosis of patients with isolated thrombotic vs. obstetric antiphospholipid syndrome: a prospective cohort study

Jiang, H., Wang, C.-H., Jiang, N., Li, J., Wu, C., Wang, Q., Li, M., Tian, X., Zhao, J., Zhao, Y., et al. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02515-w · Cited by 27 · see citing works

Anti‐phospholipid antibodies and reproductive failures

Beltagy, A., Trespìdi, L., Gerosa, M., Ossola, M. W., Meroni, P. L., & Chighizola, C. B. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13258 · Cited by 27 · see citing works

Recomendaciones de la Sociedad Española de Reumatología sobre síndrome antifosfolípido primario. Parte I: Diagnóstico, evaluación y tratamiento

Cáliz, R., Fontecha, P. D. D. C., Galindo-Izquierdo, M., Longo, F. J. L., Zamora, M. Á. M., Santamaría, A., Pliego, O. A., Lozano, M. J. C., Beltrán, M. P. D., Carmona, L., et al. (2019) · Reumatología Clínica · doi:10.1016/j.reuma.2018.11.003 · Cited by 26 · see citing works

Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis

Yang, Z., Shen, X., Zhou, C., Wang, M., Liu, Y., & Zhou, L. (2020) · Lupus · doi:10.1177/0961203320967097 · Cited by 25 · see citing works

The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies

Ruffatti, A., Tonello, M., Favarò, M., Ross, T. D., Calligaro, A., Gervasi, M. T., Gervasi, M. T., & Hoxha, A. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.10.001 · Cited by 25 · see citing works

Triple positive profile in antiphospholipid syndrome: prognosis, relapse and management from a retrospective multicentre study

Laurent, C., Ricard, L., Nguyen, Y., Boffa, J. J., Rondeau, É., Gerotziafas, G., Elalamy, I., Deriaz, S., MOREUIL, C. D., Planche, V., et al. (2023) · RMD Open · doi:10.1136/rmdopen-2022-002534 · Cited by 28 · see citing works

Effects of exercise during pregnancy in women with short cervix: Secondary analysis from the Italian Pessary Trial in singletons

Saccone, G., Berghella, V., Venturella, R., D’Alessandro, P., Arduino, B., Raffone, A., Giudicepietro, A., Visentin, S., Vitagliano, A., Martinelli, P., et al. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.08.582 · Cited by 24 · see citing works

Intrauterine fetal deaths related to antiphospholipid syndrome: a descriptive study of 65 women

Belhocine, M., Coutte, L., Silva, N. M., Morel, N., Guettrot-Imbert, G., Paule, R., Jeunne, C. L., Fredi, M., Dreyfus, M., Pietté, J. C., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1745-2 · Cited by 24 · see citing works

Thrombotic Microangiopathy in Pregnancy: Current Understanding and Management Strategies

Urra, M., Lyons, S., Teodosiu, C. G., Burwick, R. M., & Java, A. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.05.016 · Cited by 27 · see citing works

Clinical features associated with pregnancy outcomes in women with positive antiphospholipid antibodies and previous adverse pregnancy outcomes: a real-world prospective study

Li, X., Deng, X., Duan, H., Zeng, L., Zhou, J., Liu, C., Guo, X. M., & Liu, X. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05203-3 · Cited by 23 · see citing works

Midtrimester transvaginal ultrasound cervical length screening for spontaneous preterm birth in diamniotic twin pregnancies according to chorionicity

Roman, A., Saccone, G., Dude, C. M., Ward, A., Anastasio, H. B., Dugoff, L., Zullo, F., & Berghella, V. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.08.006 · Cited by 22 · see citing works

Effects of anti‐beta 2‐glycoprotein 1 antibodies and its association with pregnancy‐related morbidity in antiphospholipid syndrome

Fierro, J. J., Velásquez, M., Cadavid, A. P., & de Leeuw, K. (2021) · American Journal of Reproductive Immunology · doi:10.1111/aji.13509 · Cited by 21 · see citing works

Heparin and aspirin combination therapy restores T-cell phenotype in pregnant patients with antiphospholipid syndrome-related recurrent pregnancy loss

Wang, M., Zhang, P., Yu, S., Zhou, G., Lv, J., Nallapothula, D., Guo, C., Wang, Q., & Singh, R. R. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.108259 · Cited by 22 · see citing works

Understanding and Preventing Placenta-Mediated Pregnancy Complications

Skeith, L., Blondon, M., & Áinle, F. N. (2020) · Hämostaseologie · doi:10.1055/a-1184-8388 · Cited by 24 · see citing works

Antiphospholipid Antibodies Increase the Risk of Fetal Growth Restriction: A Systematic Meta‐Analysis

Xu, J., Chen, D., Tian, Y., Wang, X., & Peng, B. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/4308470 · Cited by 21 · see citing works

Management of pregnant women with antiphospholipid antibodies

Ruffatti, A., Favarò, M., Calligaro, A., Zambon, A., & Ross, T. D. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1565995 · Cited by 21 · see citing works

Rodent vertical sleeve gastrectomy alters maternal immune health and fetoplacental development

Spann, R. A., Lawson, W. J., Bidwell, G. L., Zamarripa, C. A., Maranon, R. O., Bandyopadhyay, S., Taylor, E. R., Reckelhoff, J. F., Garrett, M. R., & Grayson, B. E. (2017) · Clinical Science · doi:10.1042/cs20171416 · Cited by 20 · see citing works

The role of complement in normal pregnancy and preeclampsia

Burwick, R. M., Java, A., & Regal, J. F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1643896 · Cited by 19 · see citing works

Rheumatic Diseases in Reproductive Age—the Possibilities and the Risks

Grygiel‐Górniak, B., Masiero, E., Nevaneeth, B. C., & Jojy, M. M. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00901-6 · Cited by 18 · see citing works

Obstetric management of the most common autoimmune diseases: A narrative review

Fernández‐Buhigas, I. (2022) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2022.1031190 · Cited by 18 · see citing works

Obstetric anti-phospholipid syndrome: from pathogenesis to treatment

Kaneko, K., Ozawa, N., & Murashima, A. (2021) · Immunological Medicine · doi:10.1080/25785826.2021.1969116 · Cited by 18 · see citing works

Treatment of Refractory/High-Risk Pregnancies With Antiphospholipid Syndrome: A Systematic Review of the Literature

Hoxha, A., Tormene, D., Campello, E., & Simioni, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.849692 · Cited by 17 · see citing works

Maternal and foetal placental vascular malperfusion in pregnancies with anti-phospholipid antibodies

Spinillo, A., Bellingeri, C., Cavagnoli, C., Maggio, I. D., Riceputi, G., Ruspini, B., Cesari, S., & Beneventi, F. (2020) · Lara D. Veeken · doi:10.1093/rheumatology/keaa499 · Cited by 16 · see citing works

Obstetric Anti-phospholipid Syndrome: State of the Art

Gerardi, M. C., Fernandes, M. A., Tincani, A., & Andréoli, L. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0772-y · Cited by 16 · see citing works

What’s new in obstetric antiphospholipid syndrome

Branch, D. W. (2019) · Hematology · doi:10.1182/hematology.2019000043 · Cited by 16 · see citing works

Tranexamic acid for the prevention and the treatment of primary postpartum haemorrhage: a systematic review

Ferrari, F. A., Garzon, S., Raffaelli, R., Cromi, A., Casarin, J., Ghezzi, F., Uccella, S., & Franchi, M. P. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2021.2013784 · Cited by 14 · see citing works

A Summary of Chinese Expert Consensus on Fetal Growth Restriction (An Update on the 2019 Version)

Sun, L., Hu, Y., & Qi, H. (2022) · Maternal-Fetal Medicine · doi:10.1097/fm9.0000000000000158 · Cited by 14 · see citing works

Antiphospholipid Syndrome: State of the Art of Clinical Management

Depietri, L., Veropalumbo, M. R., Leone, M. C., & Ghirarduzzi, A. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07496-3 · Cited by 16 · see citing works

Low-dose aspirin and heparin treatment improves pregnancy outcome in recurrent pregnancy loss women with anti-β2-glycoprotein I/HLA-DR autoantibodies: a prospective, multicenter, observational study

Tanimura, K., Saito, S., Tsuda, S., Ono, Y., Deguchi, M., Nagamatsu, T., Fujii, T., Nakatsuka, M., Kobashi, G., Arase, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1445852 · Cited by 15 · see citing works

Use of a Feed-Forward Back Propagation Network for the Prediction of Small for Gestational Age Newborns in a Cohort of Pregnant Patients with Thrombophilia

Vicoveanu, P., Vasilache, I.-A., Scripcariu, I. S., Nemescu, D., Cărăuleanu, A., Vicoveanu, D. I., Covali, R. A., Filip, C., & Socolov, D. G. (2022) · Diagnostics · doi:10.3390/diagnostics12041009 · Cited by 13 · see citing works

Characteristics of pregnancy complications and treatment in obstetric antiphospholipid syndrome in China

Zhou, Z., Teng, J., Sun, Y., Liu, H., Cheng, X., Su, Y., Yang, C., & Ye, J. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04670-7 · Cited by 16 · see citing works

Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study

Hoxha, A., Favarò, M., Calligaro, A., Ross, T. D., Ruffatti, A. T., Infantolino, C., Tonello, M., Mattia, E., & Ruffatti, A. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1697665 · Cited by 14 · see citing works

Prevention of Pregnancy Complications in Antiphospholipid Syndrome

Czwalinna, A., & Bergmann, F. (2020) · Hämostaseologie · doi:10.1055/a-1113-0689 · Cited by 14 · see citing works

The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics

Tonello, M., Calligaro, A., Favarò, M., Ross, T. D., Veronese, P., Salvan, E., Gervasi, M. T., & Ruffatti, A. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05766-1 · Cited by 14 · see citing works

Hydroxychloroquine as additional treatment in pregnant patients with refractory APS

Carolis, S. D., Rizzo, F., & Tabacco, S. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.08.113 · Cited by 14 · see citing works

Clinical features, risk factors, and outcomes of diffuse alveolar hemorrhage in antiphospholipid syndrome: A mixed-method approach combining a multicenter cohort with a systematic literature review

Figueroa‐Parra, G., Meade‐Aguilar, J. A., Langenfeld, H. E., González‐Treviño, M., Hocaoǧlu, M., Hanson, A. C., Prokop, L. J., Murad, M. H., Cartin‐Ceba, R., Specks, U., et al. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109775 · Cited by 13 · see citing works

Anticardiolipin Positivity Is Highly Associated With Intrauterine Growth Restriction in Women With Antiphospholipid Syndrome

Xi, F., Cai, Y., Lv, M., Jiang, Y., Zhou, F., Chen, Y., Jiang, L., & Luo, Q. (2020) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029620974455 · Cited by 13 · see citing works

Risk factors for pregnancy morbidity in women with antiphospholipid syndrome

Yang, J., & Liang, M. (2021) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2021.103315 · Cited by 13 · see citing works

Association of B Cells with Idiopathic Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis

Ângelo‐Dias, M., Martins, C. G., Dias, S. S., Borrego, L. M., & de Lima, J. J. A. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315200 · Cited by 13 · see citing works

The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low‐risk for chromosomal abnormalities

Foddai, S. G., Radin, M., Cecchi, I., Gaito, S., Orpheu, G., Rubini, E., Barinotti, A., Menegatti, E., Mengozzi, G., Roccatello, D., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15053 · Cited by 13 · see citing works

Hydroxychloroquine and pregnancy outcomes in patients with anti-phospholipid syndrome: a systematic review and meta-analysis

Berman, A., Kenet, G., Lubetsky, A., Agmon‐Levin, N., Soffer, S., Barg, A. A., Levy‐Mendelovich, S., Cohen, O., Radinsky, L. W., Lalezari, S., et al. (2025) · RMD Open · doi:10.1136/rmdopen-2025-005825 · Cited by 12 · see citing works

Low-Molecular-Weight Heparin in Preeclampsia: Effects on Biomarkers and Prevention: A Narrative Review

Baroutis, D., Koukoubanis, K., Tzanis, A. Α., Theodora, M. K., Rizogiannis, K., Bairaktaris, D., Manios, E., Pergialiotis, V., Alexopoulos, E. C., & Daskalakis, G. (2025) · Biomedicines · doi:10.3390/biomedicines13102337 · Cited by 12 · see citing works

Obstetric antiphospholipid syndrome carries an increased lifetime risk for obstetric and thrombotic complications—a population-based study

Rhein, A. K., Rabinovich, A., Abuhasira, R., Lubaton-Barshishat, S., & Erez, O. (2024) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2024.102430 · Cited by 12 · see citing works

The impact of various entities of antiphospholipid antibodies positivity on adverse pregnancy outcome. An epidemiological perspective

Spinillo, A., Bellingeri, C., Maggio, I. D., Riceputi, G., Pandolfi, M. P., Spada, C., Alpini, C., Montecucco, C., & Beneventi, F. (2021) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2021.103304 · Cited by 12 · see citing works

Recurrent Pregnancy Loss: Immunological aetiologies and associations with mental health

Laijawala, R. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100868 · Cited by 12 · see citing works

Biochemical and clinical predictors in pregnant women with antiphospholipid syndrome and systemic lupus erythematosus: comprehensive update

Li, X., Shopit, A., & Wang, J. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06178-5 · Cited by 11 · see citing works

AN OVERVIEW OF AUTOIMMUNITY IN IMPLANTATION FAILURE: A LITERATURE REVIEW

Berestoviy, V. O., Mahmood, A. A., Berestoviy, O. O., Гінзбург, В. Г., & Говсєєв, Д. О. (2021) · Wiadomości Lekarskie · doi:10.36740/wlek202103240 · Cited by 11 · see citing works

Antiphospholipid Syndrome

Wysokinska, E. M., & Ortel, T. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-46202-0.00020-0 · Cited by 11 · see citing works

62: Obstetric outcomes in pregnant women with primary antiphospholipid syndrome according to the antibody profile: The PREGNANTS study

Saccone, G., Maruotti, G. M., Berghella, V., Sarno, L., Capone, A., & Martinelli, P. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.11.948 · Cited by 2 · see citing works

Pregnancy and Clinical Outcome Among Women with Antiphospholipid Antibody Syndrome—A Tertiary Care Center–Based Observational Study

Venkatesh, Y. S., Subbaiah, M., Kavadichanda, C. G., & Murugesan, R. (2024) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-024-01643-z

Antiphospholipid-Syndrom – Risiko für Schwangere je nach Antikörperprofil

(2017) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0043-112765

Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity

Ruffatti, A., Tonello, M., Del Ross, T., Cavazzana, A., Grava, C., Noventa, F., Tona, F., Iliceto, S., & Pengo, V. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-05-0287 · Cited by 170 · see citing works

Obstetric outcomes in patients with primary thrombotic and obstetric antiphospholipid syndrome and its relation to the antiphospholipid antibody profile

Högdén, A., Antovič, A., Berg, E., Bremme, K. A., & Chaireti, R. (2019) · Lupus · doi:10.1177/0961203319852155 · Cited by 22 · see citing works